<DOC>
	<DOCNO>NCT00911313</DOCNO>
	<brief_summary>The purpose study compare determine efficacy letrozole administration combine metformin Clomiphene infertile woman polycystic ovary syndrome ( PCOS ) respond treatment Clomiphene alone .</brief_summary>
	<brief_title>Letrozole Combined Metformin Clomiphene Citrate ( CC ) Women With CC Resistant Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Withdrawal bleed achieve use 10 mg dydrogesterone tablet 10 day stimulation . In letrozole group , 2.5 mg letrozole oral tablet ( Femara ; Novartis Pharma Services , Switzerland ) daily day 3 menses 5 day , whereas patient combine metformin-CC group ) receive metformin HCl [ Cidophage® ; Chemical Industries Development ( CID ) , Cairo , Egypt ] , 500 mg three time daily 6-8 week . Then end period , receive 150 mg CC ( Clomid® ; Global Napi Pharmaceuticals , Cairo , Egypt ) 5 day start day 3 menstruation . Patients continue treatment three successive cycle use protocol . Metformin stop pregnancy document .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>CC resistant PCOS Congenital adrenal hyperplasia Cushing syndrome Androgen secreting tumor</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>clomiphene resistance</keyword>
	<keyword>letrozole</keyword>
</DOC>